Marker Therapeutics Inc (MRKR)
4.30
+0.20
(+4.88%)
USD |
NASDAQ |
May 17, 16:00
4.30
0.00 (0.00%)
After-Hours: 20:00
Marker Therapeutics Enterprise Value: 21.39M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 21.39M |
| May 15, 2024 | 22.01M |
| May 14, 2024 | 20.32M |
| May 13, 2024 | 21.30M |
| May 10, 2024 | 21.66M |
| May 09, 2024 | 22.55M |
| May 08, 2024 | 22.90M |
| May 07, 2024 | 20.68M |
| May 06, 2024 | 21.48M |
| May 03, 2024 | 22.46M |
| May 02, 2024 | 22.28M |
| May 01, 2024 | 21.48M |
| April 30, 2024 | 20.95M |
| April 29, 2024 | 21.52M |
| April 26, 2024 | 23.08M |
| April 25, 2024 | 23.75M |
| April 24, 2024 | 24.06M |
| April 23, 2024 | 24.28M |
| April 22, 2024 | 22.19M |
| April 19, 2024 | 21.75M |
| April 18, 2024 | 21.39M |
| April 17, 2024 | 23.26M |
| April 16, 2024 | 24.06M |
| April 15, 2024 | 24.42M |
| April 12, 2024 | 23.26M |
| Date | Value |
|---|---|
| April 11, 2024 | 25.84M |
| April 10, 2024 | 28.07M |
| April 09, 2024 | 26.73M |
| April 08, 2024 | 26.82M |
| April 05, 2024 | 26.47M |
| April 04, 2024 | 28.33M |
| April 03, 2024 | 25.40M |
| April 02, 2024 | 23.71M |
| April 01, 2024 | 25.84M |
| March 28, 2024 | 23.17M |
| March 27, 2024 | 23.48M |
| March 26, 2024 | 23.35M |
| March 25, 2024 | 27.98M |
| March 22, 2024 | 28.60M |
| March 21, 2024 | 26.20M |
| March 20, 2024 | 24.95M |
| March 19, 2024 | 24.06M |
| March 18, 2024 | 23.35M |
| March 15, 2024 | 24.32M |
| March 14, 2024 | 24.67M |
| March 13, 2024 | 23.43M |
| March 12, 2024 | 22.45M |
| March 11, 2024 | 21.73M |
| March 08, 2024 | 21.38M |
| March 07, 2024 | 20.13M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-11.48M
Minimum
Feb 23 2022
356.06M
Maximum
Jul 16 2019
61.92M
Average
40.26M
Median
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 7.080M |
| Perspective Therapeutics Inc | 890.47M |
| Protalix BioTherapeutics Inc | 57.71M |
| Electromed Inc | 135.95M |
| Armata Pharmaceuticals Inc | 189.99M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.803M |
| Total Expenses (Quarterly) | 2.938M |
| EPS Diluted (Quarterly) | -0.32 |
| Earnings Yield | -21.86% |
| Normalized Earnings Yield | -52.33 |